AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/126

Authors: DCRUZ OJ GHOSH P UCKUN FM
Citation: Oj. Dcruz et al., SPERMICIDAL ACTIVITY OF CHELATED COMPLEXES OF BIS(CYCLOPENTADIENYL)VANADIUM(IV), Molecular human reproduction (Print), 4(7), 1998, pp. 683-693

Authors: EK O WAURZYNIAK B MYERS DE UCKUN FM
Citation: O. Ek et al., ANTITUMOR-ACTIVITY OF TP3(ANTI-P80)-POKEWEED ANTIVIRAL PROTEIN IMMUNOTOXIN IN HAMSTER-CHEEK POUCH AND SEVERE COMBINED IMMUNODEFICIENT MOUSEXENOGRAFT MODELS OF HUMAN OSTEOSARCOMA, Clinical cancer research, 4(7), 1998, pp. 1641-1647

Authors: NARLA RK LIU XP MYERS DE UCKUN FM
Citation: Rk. Narla et al., O-4'HYDROXYLPHENYL)-AMINO-6,7-DIMETHOXYQUINAZOLINE - A NOVEL QUINAZOLINE DERIVATIVE WITH POTENT CYTOTOXIC ACTIVITY AGAINST HUMAN GLIOBLASTOMA CELLS, Clinical cancer research, 4(6), 1998, pp. 1405-1414

Authors: UCKUN FM NARLA RK ZEREN T YANISHEVSKI Y MYERS DE WAURZYNIAK B EK O SCHNEIDER E MESSINGER Y CHELSTROM LM GUNTHER R EVANS W
Citation: Fm. Uckun et al., IN-VIVO TOXICITY, PHARMACOKINETICS, AND ANTICANCER ACTIVITY OF GENISTEIN LINKED TO RECOMBINANT HUMAN EPIDERMAL GROWTH-FACTOR, Clinical cancer research, 4(5), 1998, pp. 1125-1134

Authors: UCKUN FM NARLA RK ZEREN T YANISHEVSKI Y MYERS DE WAURZYNIAK B EK O SCHNEIDER E MESSINGER Y CHELSTROM LM GUNTHER R EVANS W
Citation: Fm. Uckun et al., IN-VIVO TOXICITY, PHARMACOKINETICS, AND ANTICANCER ACTIVITY OF GENISTEIN LINKED TO RECOMBINANT HUMAN EPIDERMAL GROWTH-FACTOR, Clinical cancer research, 4(5), 1998, pp. 1125-1134

Authors: UCKUN FM NARLA RK JUN X ZEREN T VENKATACHALAM T WADDICK KG ROSTOSTEV A MYERS DE
Citation: Fm. Uckun et al., CYTOTOXIC ACTIVITY OF EPIDERMAL GROWTH FACTOR-GENISTEIN AGAINST BREAST-CANCER CELLS, Clinical cancer research, 4(4), 1998, pp. 901-912

Authors: UCKUN FM NARLA RK JUN X ZEREN T VENKATACHALAM T WADDICK KG ROSTOSTEV A MYERS DE
Citation: Fm. Uckun et al., CYTOTOXIC ACTIVITY OF EPIDERMAL GROWTH FACTOR-GENISTEIN AGAINST BREAST-CANCER CELLS, Clinical cancer research, 4(4), 1998, pp. 901-912

Authors: GHOSH S ZHENG YG JUN X NARLA RK MAHAJAN S NAVARA C MAO C SUDBECK EA UCKUN FM
Citation: S. Ghosh et al., HYDROXY-BETA-METHYL-N-[4-(TRIFLUOROMETHOXY)PHENYL] PROPENAMIDE - AN INHIBITOR OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR TYROSINE KINASE WITH POTENT CYTOTOXIC ACTIVITY AGAINST BREAST-CANCER CELLS, Clinical cancer research, 4(11), 1998, pp. 2657-2668

Authors: NARLA RK LIU XP KLIS D UCKUN FM
Citation: Rk. Narla et al., INHIBITION OF HUMAN GLIOBLASTOMA CELL-ADHESION AND INVASION BY (4'-HYDROXYLPHENYL)-AMINO-6,7-DIMETHOXYQUINAZOLINE (WHI-P131) AND -4'-HYDROXYLPHENYL)-AMINO-6,7-DIMETHOXYQUINAZOLINE (WHI-P154), Clinical cancer research, 4(10), 1998, pp. 2463-2471

Authors: MESSINGER Y YANISHEVSKI Y EK O ZEREN T WAURZYNIAK B GUNTHER R CHELSTROM L CHANDANLANGLIE M SCHNEIDER E MYERS DE EVANS W UCKUN FM
Citation: Y. Messinger et al., IN-VIVO TOXICITY AND PHARMACOKINETIC FEATURES OF B43 (ANTI-CD19)-GENISTEIN IMMUNOCONJUGATE IN NONHUMAN-PRIMATES, Clinical cancer research, 4(1), 1998, pp. 165-170

Authors: MESSINGER Y YANISHEVSKI Y EK O ZEREN T WAURZYNIAK B GUNTHER R CHELSTROM L CHANDANLANGLIE M SCHNEIDER E MYERS DE EVANS W UCKUN FM
Citation: Y. Messinger et al., IN-VIVO TOXICITY AND PHARMACOKINETIC FEATURES OF B43 (ANTI-CD19)-GENISTEIN IMMUNOCONJUGATE IN NONHUMAN-PRIMATES, Clinical cancer research, 4(1), 1998, pp. 165-170

Authors: GAYNON PS BOSTROM BC REAMAN GH SATHER HN TRIGG ME TUBERGEN DG UCKUN FM
Citation: Ps. Gaynon et al., CHILDRENS CANCER GROUP (CCG) INITIATIVES IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, International journal of pediatric hematology/oncology, 5(2-4), 1998, pp. 99-114

Authors: WILLIAMS MD ROSTOVTSEV A NARLA RK UCKUN FM
Citation: Md. Williams et al., PRODUCTION OF RECOMBINANT DT(CT)GMCSF FUSION TOXIN IN A BACULOVIRUS EXPRESSION VECTOR SYSTEM FOR BIOTHERAPY OF GMCSF-RECEPTOR POSITIVE HEMATOLOGIC MALIGNANCIES, Protein expression and purification (Print), 13(2), 1998, pp. 210-221

Authors: EK O GAYNON P ZEREN T CHELSTROM LM MYERS DE UCKUN FM
Citation: O. Ek et al., TREATMENT OF HUMAN B-CELL PRECURSOR LEUKEMIA IN SCID MICE BY USING A COMBINATION OF THE ANTI-CD19 IMMUNOTOXIN B43-PAP WITH THE STANDARD CHEMOTHERAPEUTIC DRUGS VINCRISTINE, METHYLPREDNISOLONE, AND L-ASPARAGINASE, Leukemia & lymphoma, 31(1-2), 1998, pp. 143-149

Authors: UCKUN FM SATHER HN WAURZYNIAK BJ SENSEL MG CHELSTROM L EK O SARQUIS MB NACHMAN J BOSTROM B REAMAN GH GAYNON PS
Citation: Fm. Uckun et al., PROGNOSTIC-SIGNIFICANCE OF B-LINEAGE LEUKEMIC-CELL GROWTH IN SCID MICE - A CHILDRENS-CANCER-GROUP-STUDY, Leukemia & lymphoma, 30(5-6), 1998, pp. 503-514

Authors: UCKUN FM WAURZYNIAK BJ SENSEL MG CHELSTROM L CROTTY ML GAYNON PS REAMAN GH
Citation: Fm. Uckun et al., PRIMARY BLASTS FROM INFANTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA CAUSE OVERT LEUKEMIA IN SCID MICE, Leukemia & lymphoma, 30(3-4), 1998, pp. 269-277

Authors: EK O YANISHEVSKI Y ZEREN T WAURZYNIAK B GUNTHER R CHELSTROM L CHANDANLANGLIE M SCHNEIDER E MYERS DE EVANS W UCKUN FM
Citation: O. Ek et al., IN-VIVO TOXICITY AND PHARMACOKINETIC FEATURES OF B43(ANTI-CD19)-GENISTEIN IMMUNOCONJUGATE, Leukemia & lymphoma, 30(3-4), 1998, pp. 389-394

Authors: MYERS DE SICHENEDER A CLEMENTSON D DVORAK N VENKATACHALAM T SEV AR CHANDANLANGLIE M UCKUN FM
Citation: De. Myers et al., LARGE-SCALE MANUFACTURING OF B43(ANTI-CD19)-GENISTEIN FOR CLINICAL-TRIALS IN LEUKEMIA AND LYMPHOMA, Leukemia & lymphoma, 29(3-4), 1998, pp. 329

Authors: EK O REAMAN GH CRANKSHAW DL CHELSTROM LM MYERS DE UCKUN FM
Citation: O. Ek et al., COMBINED THERAPEUTIC EFFICACY OF THE THYMIDYLATE SYNTHASE INHIBITOR ZD1694 (TOMUDEX) AND THE IMMUNOTOXIN B43(ANTI-CD19)-PAP IN A SCID MOUSEMODEL OF HUMAN B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA, Leukemia & lymphoma, 28(5-6), 1998, pp. 509-514

Authors: VIG R MAO C VENKATACHALAM TK TUELAHLGREN L SUDBECK EA UCKUN FM
Citation: R. Vig et al., RATIONAL DESIGN AND SYNTHESIS OF PHENETHYL-5-BROMOPYRIDYL THIOUREA DERIVATIVES AS POTENT NONNUCLEOSIDE INHIBITORS OF HIV REVERSE-TRANSCRIPTASE, Bioorganic & medicinal chemistry, 6(10), 1998, pp. 1789-1797

Authors: MAO C VIG R VENKATACHALAM TK SUDBECK EA UCKUN FM
Citation: C. Mao et al., STRUCTURE-BASED DESIGN OF PIPERIDINYLETHYL)]-N'-[2-(5-BROMOPYRIDYL]-THIOUREA AND IPERAZINYLETHYL)]-N'-[2-(5-BROMOPYRIDYL)]-THIOUREA AS POTENT NONNUCLEOSIDE INHIBITORS OF HIV-1 REVERSE-TRANSCRIPTASE, Bioorganic & medicinal chemistry letters, 8(16), 1998, pp. 2213-2218

Authors: VIG R MAO C VENKATACHALAM TK TUELAHLGREN L SUDBECK EA UCKUN FM
Citation: R. Vig et al., LTHIOMETHYL)THIO]-6-(BENZYL)-PYRIMIDIN-4-(1H)-ONES AS POTENT NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS OF S-DABO SERIES, Bioorganic & medicinal chemistry letters, 8(12), 1998, pp. 1461-1466

Authors: VIG R VENKATACHALAM TK JAN ST UCKUN FM
Citation: R. Vig et al., ARYL PHOSPHATE DERIVATIVES OF 3'-DEOXYTHYMIDINE ARE NOT POTENT ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS AGENTS, Antiviral chemistry & chemotherapy, 9(5), 1998, pp. 439-443

Authors: VIG R VENKATACHALAM TK UCKUN FM
Citation: R. Vig et al., D4T-5'-[P-BROMOPHENYL METHOXYALANINYL PHOSPHATE] AS A POTENT AND NONTOXIC ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS AGENT, Antiviral chemistry & chemotherapy, 9(5), 1998, pp. 445-448

Authors: HEEREMA NA SATHER HN SENSEL MG KRAFT P NACHMAN JB STEINHERZ PG LANGE BJ HUTCHINSON RS REAMAN GH TRIGG ME ARTHUR DC GAYNON PS UCKUN FM
Citation: Na. Heerema et al., FREQUENCY AND CLINICAL-SIGNIFICANCE OF CYTOGENETIC ABNORMALITIES IN PEDIATRIC T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA - A REPORT FROM THE CHILDRENS CANCER GROUP, Journal of clinical oncology, 16(4), 1998, pp. 1270-1278
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>